News

Real-Time Process Management System Reliable to Reach Target Final Concentration

April 26, 2023

The results found that repeatability testing found all 15 processes to be with in specification for target final concentration.

Aspect Biosystems, Novo Nordisk Partner to Develop Bioprinted Tissue Therapeutics

April 25, 2023

Aspect Biosystems and Novo Nordisk A/S have announced a collaboration, development, and license agreement to develop bioprinted tissue therapeutics.

EHA Data Leak Shows Positive J&J Cancer Treatment Findings

April 25, 2023

The leaked study summary found that Carvykti (ciltacabtagene autoleucel) reduced disease progression by 74%.

Court Ruling Leaves FDA Authority in Limbo

April 24, 2023

The Supreme Court’s action leaves open the prospect of further rulings that could undermine FDA’s approval process.

BioChain Institute Extends Spatial Multiomics Services

April 24, 2023

BioChain has reached partnerships with NanoString and 10x Genomics to extend its spatial multiomics services.

JMI Laboratories and bioMérieux Enter Antimicrobial Resistance Diagnostics Partnership

April 24, 2023

JMI Laboratories and bioMérieux will work to improve microbiology diagnostics tools.

Indian Pharma Companies Poised for Surge?

April 21, 2023

A report from Business Standard highlighted India’s recent growth in the pharma sector.

GSK and BELLUS Health Enter Acquisition Agreement

April 20, 2023

GSK has reached an agreement to acquire late-stage biopharmaceutical company BELLUS Health.

FDA Grants Breakthrough Therapy Designation to SAB Biotherapeutics for Influenza Immunotherapy

April 20, 2023

SAB Biotherapeutics has received both breakthrough and fast track designations from FDA for its lead antibody drug candidate for treating influenza.

FDA’s Office of New Drugs Highlights New Research Projects for Growth

April 18, 2023

Jaeger notes that the program is focused on addressing specific scientific questions that will produce immediate impacts on how CDER and FDA make drug approval decisions.